Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Incyte Corporation
Scientific Title
A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma